SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-21-027561
Filing Date
2021-08-09
Accepted
2021-08-09 16:20:43
Documents
68
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q brhc10027807_10q.htm   iXBRL 10-Q 1390321
2 EXHIBIT 31.1 brhc10027807_ex31-1.htm EX-31.1 10239
3 EXHIBIT 31.2 brhc10027807_ex31-2.htm EX-31.2 10502
4 EXHIBIT 32.1 brhc10027807_ex32-1.htm EX-32.1 6158
10 image0.jpg GRAPHIC 28098
  Complete submission text file 0001140361-21-027561.txt   7155895

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA rckt-20210630.xsd EX-101.SCH 47754
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rckt-20210630_cal.xml EX-101.CAL 67310
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rckt-20210630_def.xml EX-101.DEF 261713
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rckt-20210630_lab.xml EX-101.LAB 738236
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rckt-20210630_pre.xml EX-101.PRE 419135
11 EXTRACTED XBRL INSTANCE DOCUMENT brhc10027807_10q_htm.xml XML 1137173
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36829 | Film No.: 211156770
SIC: 2834 Pharmaceutical Preparations